Marinus Pharmaceuticals Inc (MRNS)
0.2555
+0.02
(+7.35%)
USD |
NASDAQ |
Dec 24, 12:47
Marinus Pharmaceuticals Shareholders Equity (Quarterly): -66.74M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 7.527B |
| AbbVie Inc | 6.032B |
| Viking Therapeutics Inc | 911.45M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.62M |
| Total Liabilities (Quarterly) | 130.36M |
| Debt to Equity Ratio | -0.8269 |
| Current Ratio | 1.664 |
| Net Debt Paydown Yield | 3.46% |